Almirall And Absci Expand AI Drug Creation Collaboration Adding Second Dermatology Target

Reuters
Aug 07
Aug 7 (Reuters) - Almirall SA ::
*ALMIRALL AND ABSCI EXPAND AI DRUG CREATION COLLABORATION ADDING SECOND DERMATOLOGY TARGET
*ABSCI ELIGIBLE FOR UP TO $650 MILLION IN PAYMENTS
*SELECTS SECOND TARGET AIMED AT DERMATOLOGICAL INDICATIONS IN AI DRUG COLLABORATION

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 07-AUG-202506:00:00.263 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10